The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease.
Y Maneuf, AA.R Crossman, J. Brotchie
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease.'. Together they form a unique fingerprint.